Personalized medicine is one of the key areas where the Illumina Accelerator is making a significant impact. By supporting startups that are developing genomic-based diagnostics and therapies, the accelerator is helping to tailor cancer treatment to individual patients. This personalized approach can lead to more effective treatments, fewer side effects, and improved patient outcomes.
